Benjamin M. Segal

Management’s tone change, post earnings announcement drift and accruals

Ronen Feldman, Suresh Govindaraj, Joshua Livnat et al. · Review of Accounting Studies · 2009 · 666 citations

Accounting, Accounting Practice, Business +4

IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition

Mark A. Kroenke, Thaddeus Carlson, Anuska V. Andjelkovic et al. · The Journal of Experimental Medicine · 2008 · 575 citations · Full text

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Benjamin M. Segal, Cris S. Constantinescu, Aparna Raychaudhuri et al. · The Lancet Neurology · 2008 · 472 citations

Subcutaneous Injections, Autoimmune Disease, Systemic Scleroderma +10

An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease

Benjamin M. Segal, Bonnie K. Dwyer, Ethan M. Shevach · The Journal of Experimental Medicine · 1998 · 470 citations · Full text

Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease

Irah L. King, Travis L. Dickendesher, Benjamin M. Segal · Blood · 2009 · 431 citations · Full text